Javier Ros

29PUBLICATIONS
138CO-AUTHORS
Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 29, 2026
Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial.

|Sep 29, 2026
Peripheral Blood as the Sole Source for Cancer Neoantigen and Reactive T-Cell Discovery.

|May 04, 2026
Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients.

|Dec 04, 2025
Mosperafenib, a Novel Paradox-Breaker BRAF Inhibitor with Potent Preclinical Activity in BRAF-Mutated Colorectal Cancer.

Florian Renner, Jan Eckmann, Cornelia Handl

|Jan 08, 2025
Real-World Data of Patients with BRAF V600E-Mutated Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil.

Javier Ros, Jose Maria Ucha, Eduardo Garcia-Galea

|Jul 17, 2024
Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei.

Jordi Martínez-Quintanilla, Débora Cabot, Doménico Sabia

Pageof 5

Frequent Collaborators

14 joint publications

Josep Tabernero

13 joint publications

Iosune Baraibar

10 joint publications

Elena Elez

5 joint publications

Marta Rodríguez-Castells